KPO
Member-
Posts
619 -
Joined
Content Type
Profiles
Forums
Events
Everything posted by KPO
-
From the tender offer statement on sec.gov: “Fairfax estimates that the paid-up capital per Share on the date hereof is approximately C$316.76 (which, for illustrative purposes, is US$252.40 per share when the aggregate C$ paid-up capital balance is converted to US$ using the C$/US$ Bank of Canada average daily exchange rate on November 16, 2021) (and following the Expiration Date, Fairfax will advise Shareholders of any material change to this estimate). As a result, Fairfax expects that Non-Canadian Resident Shareholders who sell Shares pursuant to the Offer will be deemed to receive a dividend for purposes of the Tax Act.” My read is the amount paid of ~$247/ share is the paid-up capital referenced above adjusted for the current exchange rate and a subsequent payment will be made for the “dividend” once Computershare validates the appropriate tax treatment of the account with the brokerage entity.
-
I’m seeing something similar with Fidelity.
-
Appreciate the idea. Would you be willing to share your thought process on why it might outperform?
-
Merry Christmas and Happy New Year to all on the board. I’m a relatively new participant, but a long time observer that really appreciates the generally intelligent back and forth on investment ideas. I hope to meet many of you in the new year at the Berkshire, Fairfax and/or FRP annual meetings.
-
Yes, I get the full dividend and when I’ve sold in the past they’ve not withheld the 15%, so I think I’m good. Thanks!
-
For the avoidance of doubt, does the 15% Canadian withholding apply to tax advantaged accounts in the US (I.e Traditional IRAs, Roth IRAs, etc.)? I didn’t see a reference to this in the offering document.
-
Thanks for the response. That’s my view as well. I already have a position I intend to hold, but bought more specifically for the tender, which I’m also fine to hold short-term for the reasons you outlined if the tender doesn’t work out.
-
Thank you. I’d be interested in how folks are tendering. At $500, slightly less (e.g. $495, $490, etc.) or at the prevailing offer? I’ve obviously spent no time on this idea, but it became too good to pass up mid-day today….
-
I haven’t really followed this auction closely, but intrigued now that we’re near the deadline and the stock is where it is. What’s the purchase cutoff date.
-
VIAC, JWN, KMI, & ENB
-
Joining the MSGE fun in hopes the Sphere gets completed without drowning otherwise iconic assets in its wake. Initiated starter at $62.
-
I’m showing about 5X TTM EBITDA for the remainder, and I believe KOF and Heineken are close to fair value currently. I view this as reasonably priced, but not cheap, exposure to Latam through a fairly steady business. It was a fair bit cheaper when I bought, but I’ll hold here for the geographic diversification. That said, I am scratching my head at the distribution acquisitions in the US, but this hasn’t yet been material to their business. I’ll continue to monitor though.
-
I also bought FMX several times in March of 2020 and still hold it. I’d be interested in your thesis if you don’t mind sharing.
-
VIAC
-
I can get my mind around Resolute and Stelco as natural hedges for their property insurance exposure (which has effectively mitigated their inflation exposure the last year or so), but holdings like BB and Recipe just seem like nationalism plays that will never drive material value creation. I hope I’m wrong, but I also don’t think it matters much because they’ve done very well with Digit and seem to be managing the insurance business well. This isn’t Berkshire and never will be, but we seem to all agree it is a good trade in the $400’s.
-
I had similar thoughts. At minimum it impacts the TRS value further inflating book at the end of the quarter (if these gains hold post 12/23). On a separate note, what was the remaining amount on their repurchase authorization? If this wasn’t exhausted then why announce this until they closed it out at much lower recent prices?
-
I don’t have a position on Peloton, and the list after them in your post seems impressive, but is there any research to suggest NPS is a good leading indicator of long term shareholder returns?
-
And $1.8B more repurchases in October.
-
Based on the purchase valuation and the IPO price it looks like a ~$350M gain, so great ROI, but probably not a material mark for Berkshire book value. I guess if anything this and things like Stone show that Ted & Todd have great potential for finding growth investments earlier in their growth trajectory than the AAPL’s & KO’s of the world. Will be interesting to see if they can do this at the scale a company as large as Berkshire requires.
-
I guess as in sports I’m not a fan of saying “if you omit the crucial three or four mistakes we would have had wild success.” Great, but once an interception is thrown you don’t get a do over. I’m cautiously optimistic about Fairfax going forward, but these are the same people that exercised a fair bit of poor judgement in recent history.
-
I don’t understand the BB hold at levels it got to early this year, but I kind of understand why a company heavily into property insurance might want to own companies that benefit from their claims. It’s like when BRK owned Axalta. How much does GEICO spend on auto paint each year? Might as well capture some of that margin in house.
-
https://www.barrons.com/articles/canadian-steelmaker-stelco-is-a-low-cost-producer-and-has-an-investor-friendly-ceo-how-that-could-boost-the-stock-51633365262
-
I think we’re generally aligned here in terms of this being a trade vs a buy and hold forever investment, but I’m not quite looking at Prem through the bad actor / Biglari scumbag lens. If I thought his MO was to screw shareholders I wouldn’t be here. BTW, I agree 100% on your strategic review point, but the IPOs are a form of that, so they’re moving in the right direction in that regard.
-
I don’t know that these things are mutually exclusive. Sometimes I buy stocks that are just plain cheap and I’m willing to invest in the time it takes for mean reversion (Fairfax & T now, KMI, WMB, RDSB & BRK in March of 2020) and sometimes I buy things with an obvious catalyst (MRK is my most recent example), and sometimes you just buy things with a nice tailwind (APTS last fall). The objective is to maximize returns on a risk adjusted basis, so spreading bets makes sense to me as 100% catalyst-based investing doesn’t always work out.
-
I agree 100%. It’s like Russian dolls. I’m of the opinion that when you account for the recent behaviors of the CCP, such as the “common prosperity fund” (AKA unforeseen tax), India represents a more interesting and predictable investment option than China. And from a book value perspective at ~$400USD you mathematically get a free rider on India in that the discount to book effectively writes Digit and Fairfax India to zero.